Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Oral Peptides: FAQs on Bioavailability, Safety, and Clinical Use AJMC